Article ID Journal Published Year Pages File Type
5702541 Urologic Oncology: Seminars and Original Investigations 2017 8 Pages PDF
Abstract
We show TPX2, a regulator of Aurora-A, is associated with high grade and stage of ccRCC, and is an independent predictor of recurrence. Future studies are warranted testing its role in ccRCC biology, and its potential as a therapeutic target.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma
Authors
, , , , , , , , , , , , ,